This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang University. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Xujun Zou: Innovator in Hybrid Ligands and Biomimetic Chromedia
Introduction
Xujun Zou is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of chromatography through his innovative work on hybrid ligands and biomimetic chromedia. His research focuses on enhancing the efficiency of antibody separation processes.
Latest Patents
Xujun Zou holds a patent for a "Hybrid ligand, hybrid biomimetic chromedia and preparing method and use thereof." This invention involves a hybrid ligand that utilizes a hydrophilic porous microsphere as a substrate in chromatography. The microsphere is activated with allyl bromide and undergoes bromo-alcoholization with N-bromosuccinimide, followed by coupling with the hybrid ligands. The sequence of the hybrid ligand consists of phenylalanine-tyrosine-glutamine-5-aminobenzimidazole. This innovative approach allows for effective antibody separation while maintaining high selectivity.
Career Highlights
Xujun Zou is affiliated with Zhejiang University, where he continues to advance research in his field. His work has garnered attention for its practical applications in biotechnology and pharmaceuticals. He has successfully developed methods that improve the elution requirements for antibody separation, making significant strides in the efficiency of chromatographic techniques.
Collaborations
Xujun Zou collaborates with notable colleagues, including Shanjing Yao and Dongqiang Lin. Their combined expertise contributes to the advancement of research in hybrid ligands and biomimetic materials.
Conclusion
Xujun Zou's innovative work in hybrid ligands and biomimetic chromedia represents a significant advancement in chromatography. His contributions are poised to enhance the efficiency of antibody separation processes, showcasing the importance of innovation in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
